Intermediates
2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene
Mol. Wt.: 325.63
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
Mol. Wt.: 339.61
[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride]
Mol. Wt.: 228.6
(2-Chloro-5-iodophenyl)(4-
fluorophenyl)methanone
Mol. Wt.: 360.55
Under Development
2-(4-ethoxybenzyl)-1-chloro-4-iodobenzene
Mol. Wt.: 372.63
(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone
Mol. Wt.: 386.61
Under Development
2-(5-iodo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
Mol. Wt.: 408.27
Slide For More
Sl. | Product Name | Structure | Molecule details | Cas. No. | Remarks/Uses | Specification | Status |
1 | 2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene |  | M.F.: C15H14BrClO | 461432-23-5 | Key starting material for the preparation of Dapagliflozin | In-house | Commercial |
2 | (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone |  | M.F.: C15H12BrClO2 | 461432-22-4 | Key starting material for the preparation of Dapagliflozin | In-house | Commercial |
3 | (3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-((trimethylsilyloxy)methyl)-tetrahydropyran-2-one |  | M.F.: C18H42O6Si4 Mol. Wt.: 466.86 | 32384-65-9 | Uses: It’s a silylated derivative of D-gluconolactone, an intermediate for the preparation of Dapagliflozin, Empagliflozin and Canagliflozin | In-house | Commercial |
4 | 1-(2,5-Dimethylphenyl)-2-aminoethanol Hydrochloride |  | M.F.: C10H16ClNO3 Mol. Wt.: 233.69 | 60407-53-6 | Uses: Its an intermediate for the preparation of Midodrine, Midodrine hydrochloride | - | Under Development |
2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene
M.F.: C15H14BrClO
Mol. Wt.: 325.63
461432-23-5
Key starting material for the preparation of Dapagliflozin
Complete
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
M.F.: C15H12BrClO2
Mol. Wt.: 339.61
461432-22-4
Key starting material for the preparation of Dapagliflozin
Complete
[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride]
M.F.: C6H8ClF3N4
Mol. Wt.: 228.6
762240-92-6
It’s an sitagliptin pharmaceutical intermediate for the preparation of Sitagliptin phosphate
Complete
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone
M.F.: C13H7ClFIO
Mol. Wt.: 360.55
915095-86-2
Key starting material for the preparation of Empagliflozin
Under Development
2-(4-ethoxybenzyl)-1-chloro-4-iodobenzene
M.F.: C15H14ClIO
Mol. Wt.: 372.63
1103738-29-9
Key starting material for the preparation of Dapagliflozin
Under Development
(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone
M.F.: C15H12ClIO2
Mol. Wt.: 386.61
1103738-26-6
Key starting material for the preparation of Dapagliflozin
Under Development
2-(5-iodo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
M.F.:C18H14FIS
Mol. Wt.: 408.27
898566-17-1
Key starting material for the preparation of Canagliflozin
Under Development
2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene
Mol. Wt.: 325.63
461432-23-5
Key starting material for the preparation of Dapagliflozin
Complete
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
Mol. Wt.: 339.61
Complete
[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride]
Mol. Wt.: 339.61
Complete
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone
Mol. Wt.: 360.55
915095-86-2
Under Development
2-(4-ethoxybenzyl)-1-chloro-4-iodobenzene
Mol. Wt.: 372.63
Under Development
(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone
1103738-26-6
Under Development
2-(5-iodo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
Mol. Wt.: 408.27
Under Development